Citation 164265

IZUMI,S: NAKAHARA,K: GOTOH,T: HASHIMOTO,S: KINO,T: OKUHARA,M: AOKI,H: IMANAKA,H:. (1983). ANTITUMOR EFFECTS OF NOVEL IMMUNOACTIVE PEPTIDES, FK-156 AND ITS SYNTHETIC DERIVATIVES.. 36(5)

Citation Details

Title	ANTITUMOR EFFECTS OF NOVEL IMMUNOACTIVE PEPTIDES, FK-156 AND ITS SYNTHETIC DERIVATIVES.
Authors	IZUMI,S: NAKAHARA,K: GOTOH,T: HASHIMOTO,S: KINO,T: OKUHARA,M: AOKI,H: IMANAKA,H:
Year	1983
Volume	36
Issue	5

Summary

Year: 1983

Journal: Unknown

Organisms and Their Experiments (6)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC FK-156	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC FK-156	ACTIVE
3	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	STREPTOMYCES ANTIBIOTIC FK-156	INACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC FK-156	WEAK ACTIVITY

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-47920	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-47920	ACTIVE
3	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-47920	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-46091	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-46091	INACTIVE
3	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-46091	INACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-46758	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-46758	ACTIVE
3	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-46758	INACTIVE
4	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-46758	EQUIVOCAL

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-48217	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-48217	ACTIVE
3	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	STREPTOMYCES ANTIBIOTIC DERIVATIVE FR-48217	ACTIVE

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC FK-565	ACTIVE
2	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODEANTICANCER AND/OR CYTOTOXICITY MARKER CODE	STREPTOMYCES ANTIBIOTIC FK-565	ACTIVE
3	TOXIC EFFECT(GENERAL)	PHARMACOLOGY OF COMPOUND - IN VIVOSTRUCTURE-ACTIVITY RELATIONSHIP STUDIES MARKER CODE	STREPTOMYCES ANTIBIOTIC FK-565	ACTIVE

Show SPARQL Queries (1)